PharmaEssentia Corporation announced a private placement of not more than 5,000,000 common shares on April 12, 2022. The issue price shall not be less than 80% of the reference price. The transaction has been approved by board of directors of the company.

The shares to be issued will be subject to restriction period of three years from issuance. The transaction is subject to shareholder approval.